Original Article A Novel Endometriosis Inducing Factor In Women with Endometriosis

article OA: closed CC0
View on OpenAlex
AI-generated summary by claude@2026-08, 2026-08-05

Endometriosis patient sera induced morphological changes in mesenchymal stem cells resembling endometrial cells, with a higher incidence and earlier onset in patients with moderate to severe disease.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Aim: To confirm the hypothesis of the presence of a possible endometriosis inducing factor(s) (EIF) in the blood of women with endometriosis. Patients and Methods: Forty infertile women were studied. The study group compromised of fifteen women of each three different degrees of endometriosis and fifteen women without endometriosis as a control group. Stem cells are characterized by being spindle shaped and proliferate in appropriate culture indefinitely. The women sera were co-cultured with mesenchymal stem cells (MSCs) which were followed up weekly to look for morphological changes and to detect Annexin 1 marker and ß-actin gene by reverse transcriptase polymerase chain reaction. Results: MSCs cultured with sera of cases with, mild, moderate and severe endometriosis, showed morphological changes to be columnar and cuboidal shaped cells-resembling endometrial cells and glands- by the 4th week in 60%, 60 % & 100 % respectively. These cells were detected from as early as the first week in women with moderate and severe types (20 % for each group). The percentage of the change into

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-13T18:23:49.274546+00:00
License: CC0 · commercial use OK